Upfront will use the proceeds to accelerate the commercialization of its lateral flow test, called LVOne, for triaging stroke patients in the UK, Europe, and US.

NEW YORK – What were the articles that gained the most interest from 360Dx readers last week? Here are the top five: ...

NEW YORK - Teal Health announced on Friday that its self-collection device for human papillomavirus testing has obtained US Food and Drug Administration approval. The device can be used to collect ...

Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...

Congress has passed delays to PAMA implementation, but such a pause could be less likely this year, warn industry stakeholders.

The firm filed for Chapter 11 protection on Thursday and is seeking to sell its assets after facing turmoil in recent years.

The agreement enables rapid diagnostic test manufacturing in the Africa region and will initially focus on HIV testing.

The firm reported that its total revenues jumped 9 percent in Q2, but it lowered the low end of its EPS guidance to account for the uncertainty of tariffs and other trade barriers.